M. Michelle Berrey

Early establishment of a pool of latently infected, resting CD4 ⁺ T cells during primary HIV-1 infection

Tae‐Wook Chun, Delphine Engel, M. Michelle Berrey et al. · Proceedings of the National Academy of Sciences · 1998 · 835 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

Edward Gane, Catherine Stedman, Robert H. Hyland et al. · New England Journal of Medicine · 2013 · 759 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

Tae‐Wook Chun, Delphine Engel, Stephanie B. Mizell et al. · Nature Medicine · 1999 · 409 citations

Life Sciences, Immunology, Infectious Diseases +16

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Edward Gane, Stuart K. Roberts, Catherine AM Stedman et al. · The Lancet · 2010 · 336 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

Eric Lawitz, Jay Lalezari, Tarek Hassanein et al. · The Lancet Infectious Diseases · 2013 · 328 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16